The most severe deficiency (<10% of the reference values) of ADAMTS-13 occurs in thrombocytopenic purpura, a condition characterized by large VWF multimer sizes and, consequently, an increased risk of thrombosis. This evidence concerns the gene VWF and thrombocytopenic purpura.